Here’s Why IDEXX Laboratories (IDXX) Surged in Q3

6 days ago 6

Soumya Eswaran

Mon, November 10, 2025 astatine 8:03 AM CST 3 min read

Baron Funds, an concern absorption company, released its “Baron Asset Fund” third-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. US equities continued the erstwhile quarter's rally successful the 3rd 4th of 2025. The anticipation of the Federal Reserve (the Fed) to chopped involvement rates was the superior operator down the marketplace rally. In the 3rd quarter, the money declined 4.23% (Institutional Shares) compared to 2.78% for the Russell Midcap Growth Index and an 8.18% instrumentality for the Russell 3000 Index. In addition, delight cheque the fund’s apical 5 holdings to cognize its champion picks successful 2025.

In its third-quarter 2025 capitalist letter, Baron Asset Fund highlighted stocks specified arsenic IDEXX Laboratories, Inc. (NASDAQ:IDXX). IDEXX Laboratories, Inc. (NASDAQ:IDXX) develops, manufactures, and distributes products chiefly for the companion carnal veterinary, livestock and poultry, dairy, and h2o investigating markets. The one-month instrumentality of IDEXX Laboratories, Inc. (NASDAQ:IDXX) was 11.86%, and its shares gained 62.01% of their worth implicit the past 52 weeks. On November 7, 2025, IDEXX Laboratories Inc. (NASDAQ:IDXX) banal closed astatine $708.45 per share, with a marketplace capitalization of $56.571 billion.

Baron Asset Fund stated the pursuing regarding IDEXX Laboratories, Inc. (NASDAQ:IDXX) successful its 3rd 4th 2025 capitalist letter:

"Veterinary diagnostics person IDEXX Laboratories, Inc. (NASDAQ:IDXX) contributed to show aft reporting better-than expected fiscal results. Foot postulation to veterinary clinics successful the U.S. continued to amended modestly from depressed levels, contributing to astir 10% changeless currency gross maturation successful its halfway Companion Animal conception – its champion effect successful 2 years. In addition, the institution installed 2,400 of its inVue Dx cellular analyzers, exceeding capitalist expectations, and boding good for the associated aboriginal consumable gross stream. IDEXX besides continued aggressively to repurchase its shares, signaling management’s assurance that favorable dynamics should continue. We spot expanding grounds that semipermanent secular trends astir favored ownership and favored attraction spending person structurally accelerated, and we expect IDEXX’s semipermanent maturation complaint and borderline illustration to improve."

IDEXX Laboratories Inc. (NASDAQ:IDXX) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 48 hedge money portfolios held IDEXX Laboratories Inc. (NASDAQ:IDXX) astatine the extremity of the 2nd quarter, compared to 51 successful the erstwhile quarter. IDEXX Laboratories Inc.’s (NASDAQ:IDXX) revenue increased 13% arsenic reported and 12% organically successful the 3rd 4th of 2025. While we admit the imaginable of IDEXX Laboratories, Inc. (NASDAQ:IDXX) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.